Analyst firms · BofA Securities · BIIB

BofA Securities BIIB price target and rating history

Biogen Inc. (BIIB) · Health Care

BofA Securities rates Biogen Inc. (BIIB) Neutral with a $178 price target, as of its latest action on Dec 10, 2024. It has published 3 rating actions on BIIB since December 2021, including 0 upgrades and 0 downgrades. Across 10 firms with a BIIB price target in the last 12 months, the median target is $231.50.

Current rating
Neutral
Price target
$178
Median target, all firms
$231.50
Actions on BIIB
3

BofA Securities price target on BIIB

$275$227$17820222023202420252026
BofA Securities price target on BIIB, each point a stated target, December 2021 to December 2024.

Every BofA Securities rating on BIIB

How other firms rate BIIB

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchBuy$280Oct 29, 2026
Wolfe ResearchOutperform$300Aug 13, 2026
Truist SecuritiesBuy$235Jul 13, 2026
NeedhamBuy$255Jun 8, 2026
Evercore ISIOutperformMay 15, 2026
UBSBuy$225Apr 22, 2026
Wells FargoOverweight$250Apr 20, 2026
Piper SandlerOverweight$214Apr 14, 2026
BarclaysEqual Weight$185Feb 20, 2026
H.C. WainwrightBuy$228Feb 9, 2026
HSBCReduce$143Dec 10, 2025

Questions about BofA Securities and BIIB

What is BofA Securities's price target for BIIB?
BofA Securities's latest stated price target for Biogen Inc. (BIIB) is $178, from its action on Dec 10, 2024.
What is BofA Securities's rating on BIIB?
BofA Securities rates BIIB Neutral, a neutral rating, as of Dec 10, 2024.
When did BofA Securities last change its view on BIIB?
On Dec 10, 2024, BofA Securities resumes coverage at Neutral, price target $178.
How does BofA Securities's BIIB target compare with other analysts?
Across 10 firms with a BIIB price target in the last 12 months, the median target is $231.50.

More BIIB rating histories

All BofA Securities ratingsBIIB news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.